About us

HAEMATO — Well Established

HAEMATO and all its employees are primarily oriented towards the needs of patients and customers in their daily work. Service, quality and reliability are essential elements of our customer orientation and at the same time drivers of further growth.

We will be happy to answer any questions or specific concerns you may have.

Ordering Service Germany

Phone 030 / 677 9867 – 600
Fax 030 / 677 9867 – 707

Ordering Service Austria

Phone 0800 / 293 527
Fax 0800 / 296 426

4,200 m² total area at the Site in Schönefeld

More than 7,000 customers

100 employees

28 apprentices since foundation

67 % female employees

For more than15 years, HAEMATO has been committed to actively help reduce costs in the healthcare system so that every patient can benefit from the latest therapies and treatment options, even if these are often very expensive.

With our product portfolio of off-patent and patent-protected pharmaceuticals, we contribute to an efficient supply of medicines, reducing costs for health insurance companies and thus for patients.

In the area of our own brands, the focus is on development, acquisition, licensing and distribution of prescription drugs and OTC products, special cosmetics as well as dietary supplements in the lifestyle and aesthetics sector.

Products and services of the medical-aesthetic market are increasingly in demand. Society, which is getting older and staying fit longer, wants to look their perceived age. Also due to the increased social acceptance of beauty medicine, the beauty market is a growing branch within the health market.

News

Find out about the current business development of HAEMATO AG as well as about our investor relations activities.

To the news archive

interim report

Investor News

HAEMATO AG announces figures for the first quarter of 2022. According to these figures, the Group's consolidated revenue fell to EUR 54.6 million in the first quarter (previous year: EUR 73.9 million). EBITDA fell from EUR 2.8 million in the same quarter of the previous year to EUR 2.3 million. EBIT amounted to EUR 2.0 million in the first …

Investor News

Berlin, May 3, 2022 - At today's balance sheet meeting, the annual financial statements 2021 of HAEMATO AG, which were issued with an unqualified audit certificate, were adopted. The preliminary figures were confirmed. The Executive Board and Supervisory Board will propose a dividend of EUR 1.10 per dividend-bearing share to the Annual General …

Investor News

Renewed increase in sales and strong rise in earnings after disproportionate growth of the new Lifestyle and Aesthetics business unit. HAEMATO remains on course for growth: according to preliminary IFRS financial statements, consolidated revenue in the 2021 financial year rose again by around 20% to EUR 285.0 million, after revenue growth of a good …

We are here for you.

Ordering Service Germany

Phone 030 / 677 9867 – 600
Fax 030 / 677 9867 – 707

Ordering Service Austria

Phone 0800 / 293 527
Fax 0800 / 296 426

HAEMATO Shop

PoC Testing Devices, Antigen Rapid Tests, FFP2 Masks
www.schnelltest-antigen.de

M1 SELECT Shop

Acitive igredients cosmetics | Medical skincare developed by doctors
m1-select.de/en/